IFF International Flavors & Fragrances
FY2024 10-K
International Flavors & Fragrances (IFF) filed its fiscal year 2024 10-K annual report with the SEC on Feb 28, 2025. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.
AI Filing AnalysisFY2024 10-K
Business Overview
- • Core business: Creator and manufacturer of flavors, fragrances, health & biosciences, natural ingredients for consumer products across food, personal care, pharma
- • New focus: Emphasized goodwill impairment testing for Nourish and Health & Biosciences segments with combined $7.615B goodwill balance
Management Discussion & Analysis
- • Operating cash flow $1.070B (9.3% of sales) in 2024 vs $1.439B (12.5% of sales) in 2023, decline due to working capital increase
- • Dividends paid $514M in 2024 vs $826M in 2023, dividend per share $1.60 vs $3.24; capital spending expected ~6% of sales in 2025
Risk Factors
- • Ongoing U.S. and European antitrust investigations and related class action lawsuits risk fines and operational restrictions impacting results and liquidity
- • Geopolitical tensions including Russia-Ukraine war and Israel-Hamas conflict disrupting raw material supply and operations in affected regions
Financial SummaryXBRL
Revenue
$11.5B
Net Income
$243M
Gross Margin
35.9%
Operating Margin
6.7%
Net Margin
2.1%
ROE
1.8%
Total Assets
$28.7B
EPS (Diluted)
$0.95
Operating Cash Flow
$1.1B
Source: XBRL data from International Flavors & Fragrances FY2024 10-K filing on SEC EDGAR. All figures in USD.
Other International Flavors & Fragrances Annual Reports
Get deeper insights on International Flavors & Fragrances
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.